This is an observational study that will follow patients in the course of routine care and measure pain levels, glucose assessments and drug utilization for native American patients with diabetic neuropathy
Patients with diabetic neuropathy pain will have an NS100 device implanted for chronic diabetic neuropathy pain consistent with onlabel indication. All patients will be followed for 90 days post implant to measure improvements in pain, drug utilization and glucose levels.
Study Type
OBSERVATIONAL
Enrollment
83
The NS 100 is a medical device used for the treatment of diabetic neuropathy pain. Routine observational monitoring will be performed
The medium term outcomes of neurostimulation will be assessed on diabetic neuropathy pain, glucose and drug usage
Continuum of Care Clinic
Pine Ridge, South Dakota, United States
Pain scores over time
Periodic pain scores will be measured for 90 days and possibly longer
Time frame: 90 days
glucose levels will be measured over time
Serum glucose levels will be followed on patients receiving neurostimulation
Time frame: 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.